Document is current
Any future updates will be listed below
-
Authors
Lawlor, Ailbhe https://orcid.org/0009-0008-5304-6957
Beyer, Katharina
Russell, Beth
Steinbeisser, Carl https://orcid.org/0000-0003-1493-3277
Bjartell, Anders
De Meulder, Bertrand https://orcid.org/0000-0002-2108-7657
Omar, Muhammad Imran https://orcid.org/0000-0002-1597-3126
Hulsen, Tim https://orcid.org/0000-0002-0208-8443
Butler, John
N’Dow, James
Rivas, Juan Gómez https://orcid.org/0000-0002-0556-3035
Gandaglia, Giorgio
Nicoletti, Rossella
Sakalis, Vasileios
Smith, Emma Jane
Maass, Monika
Zong, Jihong
Fullwood, Louise
Abbott, Thomas
Tafreshiha, Azadeh
Papineni, Kishore
Snijder, Robert
Horgan, Denis
Seager, Sarah
Evans-Axelsson, Susan
Ribal, Maria J.
Roobol, Monique J. https://orcid.org/0000-0001-6967-1708
Van Hemelrijck, Mieke
,
Tripathee, Sheela
Briganti, Alberto
Holtorf, Marc
Kiran, Amit
van Bochove, Kees
Moinat, Maxim
Mottet, Nicolas
Shepherd, Robert
Moris, Lisa
Lardas, Michael
Campi, Riccardo
Gacci, Mauro
Bangma, Chris
Remmers, Sebastiaan
Reich, Christian
Tilki, Derya
Auvinen, Anssi
Murtola, Teemu
Visakorpi, Tapio
Talala, Kirsi
Tammela, Teuvo
Siltari, Aino
Lejeune, Stephane
Colette, Laurence
Caputova, Simona
Auffray, Charles
Hijazy, Ayman
Kermani, Nazanin Zounemat
Lancet, Doron
Bernstein, Gabi
Wirth, Manfred
Borkowetz, Angelika
Reiche, Kristin
Kreuz, Markus
Josefsson, Andreas
Schalken, Jack
Huisman, Henkjan
Hofmarcher, Thomas
Lindgren, Peter
Torremante, Patrizia
Voss, Marc Dietrich
Lambrecht, Mark
Antoni, Laurent
Robinson, Paul
Longden-Chapman, Elaine
Burke, Danny
Licour, Muriel
Payne, Sarah
Le Mare, Sophia
Bussmann, Michael
Kotik, Daniel
Herrera, Ronald
- License Information
-
More Information
Article History
Accepted: 11 June 2024
First Online: 9 September 2024
Competing interests
: S.E.-A., J.B. and J.Z. are employees of Bayer; T.H. is an employee of Philips; R.S. and K.P. are employees of Astellas Pharma; T.A. was an employee of Astellas Pharma during the PIONEER project prior to retirement; A.B. has been a consultant and adviser for Accord, Astellas Pharma, AstraZeneca, Bayer, J&J and Pfizer and a board member, officer and trustee for Glactone Pharma, has received lecture honoraria for Accord, Astellas, AstraZeneca, Bayer, Ipsen, J&J and Merck, has participated in trials run by Astellas, Bayer, Ferring, Janssen and Pfizer, and holds stock in Glactone Pharma, LIDDS Pharma and WntResearch. All companies make products used to treat prostate cancer. The other authors declare no competing interests.
